TrialJAMA network open2022

Outcomes and Safety of Very-Low-Dose Edoxaban in Frail Patients With Atrial Fibrillation in the ELDERCARE-AF Randomized Clinical Trial.

Shintaro Akashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.